HIF1A and neoplasm: Hypoxic HIF1α<sup>-/-</sup> T cells are less able to kill tumor cells, and HIF1α<sup>-/-</sup> tumor-bearing mice are not responsive to immune checkpoint blockade (ICB) therapy, indicating loss of HIF1α in T cells is a major mechanism of therapeutic resistance to ICBs.